CHARTWELL INVESTMENT PARTNERS, LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 286 filers reported holding HAEMONETICS CORP in Q2 2020. The put-call ratio across all filers is 3.85 and the average weighting 0.1%.

Quarter-by-quarter ownership
CHARTWELL INVESTMENT PARTNERS, LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2020$888,000
-2.6%
10,1810.0%0.03%
-5.7%
Q2 2020$912,000
-56.9%
10,181
-52.0%
0.04%
-64.6%
Q1 2020$2,114,000
-61.6%
21,209
-55.8%
0.10%
-45.6%
Q4 2019$5,511,000
+40.1%
47,965
+53.8%
0.18%
+37.9%
Q3 2019$3,934,000
-84.6%
31,189
-91.1%
0.13%
-84.9%
Q1 2018$25,534,000
+35.2%
349,013
+7.3%
0.87%
+36.1%
Q4 2017$18,883,000
+24.9%
325,118
-3.5%
0.64%
+24.4%
Q3 2017$15,121,000
+10.7%
337,013
-2.6%
0.52%
+0.8%
Q2 2017$13,659,000
-6.7%
345,881
-4.1%
0.51%
-3.9%
Q1 2017$14,640,000
+1.2%
360,856
+0.2%
0.53%
+7.9%
Q4 2016$14,472,000
+8.2%
360,006
-2.6%
0.49%
+107.6%
Q3 2016$13,380,000
+13.8%
369,513
-8.9%
0.24%
+13.3%
Q2 2016$11,759,000
-17.1%
405,613
+0.1%
0.21%
-21.6%
Q1 2016$14,180,000
+11.7%
405,388
+3.0%
0.27%
+3.1%
Q4 2015$12,692,000
-0.1%
393,663
+0.2%
0.26%
-4.8%
Q3 2015$12,704,000
-25.7%
393,063
-5.0%
0.27%
-18.3%
Q2 2015$17,107,000
-8.2%
413,613
-0.2%
0.33%
-7.7%
Q1 2015$18,625,000
+21.7%
414,626
+1.4%
0.36%
+13.1%
Q4 2014$15,308,000
-12.1%
409,079
-18.0%
0.32%
-18.4%
Q3 2014$17,418,000
+14.4%
498,799
+15.6%
0.39%
+23.7%
Q2 2014$15,223,000431,4790.32%
Other shareholders
HAEMONETICS CORP shareholders Q2 2020
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders